| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A clinician's perspective on a long time to publish
|
Peyrade, Frederic
|
|
2017
|
4 |
1 |
p. e11-
1 p.
|
artikel
|
| 2 |
A statistician's perspective on a long time to publish
|
Dueck, Amylou C
|
|
2017
|
4 |
1 |
p. e12-
1 p.
|
artikel
|
| 3 |
Bendamustine–rituximab in mantle cell lymphoma
|
Lipsky, Andrew
|
|
2017
|
4 |
1 |
p. e2-e3
nvt p.
|
artikel
|
| 4 |
Clinical trial reporting: an evolving process
|
The Lancet Haematology,
|
|
2017
|
4 |
1 |
p. e1-
1 p.
|
artikel
|
| 5 |
Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group
|
Peyrade, Frédéric
|
|
2017
|
4 |
1 |
p. e46-e55
nvt p.
|
artikel
|
| 6 |
Consolidation anti-CD22 fractionated radioimmunotherapy with 90Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial
|
Kraeber-Bodere, Françoise
|
|
2017
|
4 |
1 |
p. e35-e45
nvt p.
|
artikel
|
| 7 |
Ofatumumab: another way to target CD20 in Waldenström's macroglobulinaemia?
|
Buske, Christian
|
|
2017
|
4 |
1 |
p. e4-e5
nvt p.
|
artikel
|
| 8 |
Once-weekly ofatumumab in untreated or relapsed Waldenström's macroglobulinaemia: an open-label, single-arm, phase 2 study
|
Furman, Richard R
|
|
2017
|
4 |
1 |
p. e24-e34
nvt p.
|
artikel
|
| 9 |
Radioimmunotherapy of lymphoma: an underestimated therapy option
|
Hohloch, Karin
|
|
2017
|
4 |
1 |
p. e6-e7
nvt p.
|
artikel
|
| 10 |
Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi
|
Visco, Carlo
|
|
2017
|
4 |
1 |
p. e15-e23
nvt p.
|
artikel
|
| 11 |
58th American Society of Hematology Annual Meeting
|
Smith, Lan-Lan
|
|
2017
|
4 |
1 |
p. e13-e14
nvt p.
|
artikel
|
| 12 |
Time to publish: challenging the performance of cooperative group lymphoma trials
|
Federico, Massimo
|
|
2017
|
4 |
1 |
p. e8-e10
nvt p.
|
artikel
|
Tijdschrift beschrijving